Market Cap (In KRW)
1074.45 Billion
Revenue (In KRW)
655.67 Billion
Net Income (In KRW)
-467.71 Billion
Avg. Volume
172.53 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7870.0-15340.0
- PE
- -
- EPS
- -
- Beta Value
- 0.955
- ISIN
- KR7137310009
- CUSIP
- -
- CIK
- -
- Shares
- 117813252.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Hyo Keun Lee
- Employee Count
- -
- Website
- https://www.sdbiosensor.com
- Ipo Date
- 2021-07-16
- Details
- SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.
More Stocks
-
LIKHITHALikhitha Infrastructure Limited
LIKHITHA
-
ENMPFEnsurge Micropower ASA
ENMPF
-
GCLTGainClients, Inc.
GCLT
-
AMMPFAmmPower Corp.
AMMPF
-
PCF
-
4175coly Inc.
4175
-
AMEGF
-
2376Scinex Corporation
2376